Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer's disease- diabetes type 2 linkage via an enzoinformatics study.
S. M. Rizvi, Shahnawaz Shakil, D. Biswas, S. Shakil +3 more

